Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Copyright West LLC. Minimum 15 minutes delayed.

Press Releases
CHF Solutions to Exhibit at Heart Failure University
December 5, 2018
EDEN PRAIRIE, Minn. , Dec. 05, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced that it will be exhibiting at Heart Failure University from December 7-9, 2018 at the Los Angeles Airport Marriott , Los Angeles, Calif. “Heart Failure University is a unique venue as cardiology
Read More
CHF Solutions to Present at the 11th Annual LD Micro Main Event
November 28, 2018
CHF Solutions to Present at the 11th Annual LD Micro Main Event Eden Prairie, Minn. / ACCESSWIRE / November 28, 2018 / CHF Solutions (Nasdaq: CHFS), today announced that it will be presenting at the 11 th annual LD Micro Main Event on Wednesday, December 5 th at 7:30AM PST /10:30AM EST.
Read More
CHF Solutions Launches Educational Webinar Discussing the Benefits of Aquadex FlexFlow® Therapy Following Cardiovascular Surgery with Cardiovascular Surgeon, Daniel Beckles, M.D., Ph.D.
November 15, 2018
EDEN PRAIRIE, Minn. , Nov. 15, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), today announces the launch of its new educational webinar featuring Daniel Beckles , M.D., Ph.D., director of Minimally Invasive Cardiothoracic Surgery at UHS Heart and Vascular Institute , Vestal, N.Y.  The
Read More
View all press releases »

Events & Presentations

There are currently no events to display.
View all events & presentations »